Antimicrobial Crisis: A Silent Threat Claiming Lives - Insights from Dr. Robin Patel - Insights
Globally, five million deaths are associated with bacterial antimicrobial resistance each year, but the complexity of the issue is there is no single solution because we need to use antibiotics. It’s about finding a different way to live...
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D. - Insights
Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and...
Understanding a Broken Heart: Genetic Testing After Sudden Cardiac Death - Insights
PACE/State of FLPresentation Recording Coming Soon Sudden cardiac death (SCD) is a devastating event that occurs unexpectedly, often without any prior symptoms. This webinar will discuss how postmortem genetic testing may be used in...
Urinary Steroid Profile [Test in Focus] - Insights
Irina Bancos, M.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be taken...
Sickle cell disease: How new technologies are transforming patient lives - Insights
In this “Future Direction of Laboratory Medicine” webinar, Maggie DiGuardo, M.D., and Justin Juskewitch, M.D., Ph.D., will review the current knowledge regarding sickle cell disease from its genetic cause to the myriads of effects it can...
Mayo Clinic Laboratory and pathology research roundup: March 15 - Insights
This Feature Includes: Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data.
Jason Hipp, M.D., Ph.D., named chair of DLMP's new Division of Clinical Informatics - Insights
Dr. Hipp is a board-certified pathologist with fellowship training in pathology informatics, as well as artificial intelligence, machine, and deep-learning experience.
Molecular Detection for Tuberculosis Drug Resistance [Test in Focus] - Insights
Nancy Wengenack, Ph.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be...
4 statistics that showcase the broad impact of laboratory medicine - Insights
Medical Laboratory Professionals Week is a time to appreciate the profound impact of laboratory medicine on healthcare and innovation.
New Test Options for NTRK Gene Fusions - Insights
The presence NTRK gene fusions is one of the eligibility requirements for the recently FDA-approved therapy Vitrakvi (larotrectinib), a therapy indicated in adult and pediatric patients with solid tumors regardless of the type of tumor....